Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't think it is competition but added value.
How do you seal the HOCL and then expect it to be effective through the seal. I have to continue to evaluate it.
Also HOCL is still needed that is what our on-site machines are for.
If a hospital wants to seal our HOCL that is on them and nothing to effect our relationship. If a hospital wants to use it they could buy the sealant and use our equipment to administer it. It will add additional time to the process.
They may have landed a whole medical system in the UK however there is real money to be Made In the Good ole USA:
Top 10 largest health systems by member hospitals
HCA Healthcare: 214
CommonSpirit Health: 197.
Universal Health Services: 170.
Department of Veterans Affairs: 162.
Encompass Health Corporation: 123.
Ascension Health: 117.
Select Medical Corporation: 113.
Community Health Systems: 100.
Tenet Healthcare: 87
LifePoint Health: 86
Health systems, also referred to as integrated delivery networks (IDNs), are networks of providers and care facilities that are formed with the goal of improving clinical and quality performance. IDNs help to ensure that patients receive the best care outcomes for the lowest costs, and usually offer a full range of healthcare services from preventative to post-acute care.
Each health system is different in terms of size, specialty, and membership makeup. According to Definitive Healthcare data, approximately 78 percent of hospitals belong to an IDN—up from 75 percent in 2018.
Top 10 health systems by net patient revenue
HCA Healthcare: $42,673,974,296
Kaiser Permanente: $29,176,611,660
CommonSpirit Health: $28,358,722,418
Ascension Health: $18,788,901,219
Providence St. Joseph Health: $16,286,062,476
Kaiser Permanente Northern California: $14,359,957,345
Tenet Healthcare: $14,140,396,155
Kaiser Permanente Southern California: $14,011,636,037
Trinity Health: $13,737,577,562
University of California Health: $13,032,563,332
The top health systems listed here reported a combined net patient revenue of over $204 billion as of July 2020—making these networks a lucrative sales and marketing opportunity for organizations selling into the healthcare market.
Large IDNs like HCA Healthcare, Kaiser Permanente, and others often act as group purchasing organizations (GPOs) for their member hospitals. This means that the health systems negotiate with vendors to receive lower prices for supplies and services. According to Definitive Healthcare data, about 93 percent of U.S. hospitals are affiliated with a GPO—up from 84 percent in 2019.
By understanding the pricing structures achieved by GPOs, an IDN may be able to further negotiate on behalf of its member facilities. Additionally, many IDNs service a local region, giving them a unique ability to identify the needs of a defined community and address pricing needs accordingly, in a way that nationwide IDNs or GPOs may be unable to match.
Collectively, the largest health systems manage more than 1,300 hospitals—nearly 20 percent of active hospitals in the United States. This could give these hospitals an advantage in lowering care costs. In addition to negotiating purchasing prices, health systems also help to keep patient referrals in-network. This improves care coordination, enhances the patient experience, and prevents revenue loss by referring outside of a hospital's network.
https://blog.definitivehc.com/top-10-largest-health-systems
It already happened in NYC where hospitals in the same network leased Annihilyzers.
This is the consultant announcement from the 2020 1st 10Q NOTE 12. SUBSEQUENT EVENTS:
On July 8, 2020, the Company entered into a consulting agreement. Pursuant to the agreement the consultant will provide business development and introductory services for a period of five years in consideration for the issuance of 1,000,000 common shares of the Company and a 5% commission, paid in shares, for any investments brokered.
I sent IR some questions (2 weeks ago)about our recent hire:
Does anyone here have any info on the consultant?
I have some questions about the consultant that was hired July 8, 2020.
1. Who is it?
2. Resume or background?
3. Have they brokered any investments yet?
4. What markets are he/she targeting?
5. U.S. only or International too?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157840728
On or about June 17, 2020 PCTL had at least 25 Annihilyzers in 25 different hospitals.
Since then?
At least 10 more system installs on the Horizon:
Following up on an earlier release, a system installation was performed for an existing hospital client in NYC through PCTL’s primary healthcare distributor, ACE Janitorial Services. This installation was completed in mid-June, the last of three scheduled installations mentioned in an April 14th press release. The other two installations mentioned in the same announcement were completed and mentioned in a release on May 8th of this year.
Additional and ongoing activities in the US Healthcare market include, but are not limited to:
Installation of 5 additional systems with an existing NYC Hospital client.
Pending final approval for an additional installation of two systems at a third, existing NYC Hospital client.
In the quoting phase, an additional system order is pending approval for a large hospital network in upstate New York.
In the quoting phase, an additional system order is pending approval for a large hospital network in Connecticut.
In the quoting phase, an additional system order is pending approval for a large hospital network in Tennessee.
System orders which have reached the quoting phase, barring any unforeseen restrictions or difficulties, should receive final approval and be installed within 30-60 days. Existing healthcare clients awaiting final approval should see installations commence within 30-60 days.
Hopefully the system orders in the quoting phase will be done before the end of the quarter.
I would imagine PCTL is very busy building systems as 5 are needing now and 2 are awaiting final approval. I suspect the systems orders for upstate New York, Connecticut and Tennessee will be for multiple systems as they are hospitals networks not single hospitals.
This is certainly a sign of a growing company on the move to becoming more successful with many different avenues and systems configurations to get there per 2019 10K:
Annihilyzer Infection Control System – Hospital/Healthcare
Annihilyzer Infection Control System – Rack Model
Hydrolyte Generator – Large and Medium Volume
SurvivaLyte Manual Generator – Small Volume
Annihilyzer Hospital 360 SMART Spray Cart
School/Hospitality Industry and General Business 360 SMART Spray Cart
Other models of Hydrolyte® generating equipment are in research and development.
Markets: The primary applications for the Hydrolyte® technology are in cleaning, sanitizing, and disinfecting in a variety of market sectors and settings, including:
Institutional facilities, such as hospitals, nursing homes, hotels, correctional facilities and schools;
The agriculture industry for pre- and post-harvest disinfection of crops, sanitization in food processing, and certain applications in animal husbandry;
The oil and gas industry where Hydrolyte® can provide a process to disinfect water used in hydraulic fracking processes (“frac water”) and to kill sulfate reducing bacteria in “sour” oil and gas wells; and Catholyte can be used to clean equipment and aid in product recovery when applied “down hole”; and.
Other potential market opportunities are available, e.g., disinfecting and sanitizing of water in public and private water systems and industrial waste-water systems.
Management determined that the most direct paths to rapid revenue and earnings growth are in the institutional facilities and agriculture markets, although the agricultural market present some EPA-related barriers. The preponderance of business development and marketing resources are currently being devoted to these two markets. Management intends to also work to maintain our position and expertise in the oil and gas industry to assure that current customer relationships are maintained, business opportunities at hand are pursued and that we are properly positioned for a roll-out as, and when, drilling activity increases as anticipated. As further market development occurs, the Company anticipates considering and acting upon factual information.
Institutional Facilities: Hospitals, Health Care Facilities & Schools
PCT Corp.’s senior research and development personnel have developed several models of equipment to be deployed as a state-of-the-art integrated product dispensing, tracking (patented RFID tracking features) and management systems for applications in the institutional facilities market. This integrated technologies solution, branded as PCT’s Annihilyzer® Infection Control System, has been designed most particularly for hospitals, large long-term care, assisted living and nursing home facilities. In various configurations (utilizing a rack model) it in can be deployed in other health care facilities including urgent care centers, medical, dental and veterinary offices. It is adaptable to deployment in schools, prisons, hotels, and many other facilities, although the primary marketing and sales goal for PCT Corp. remains with the hospital market. A complete and custom turn-key cleaning and disinfection program solution can be provided to each facility.
The Company created and offers a proprietary automated state-of-the-art Electrostatic Spray Cart for use in hospital (or hospitality-industry) settings, allowing for rapid disinfecting of rooms once a patient (guest) has vacated the room. This system is designed to reduce the turnover time required between patients/guests, potentially increasing revenue opportunities, and improving efficiency of hospital/hotel personnel. A smaller scaled model of the electrostatic spray cart is available to other industries, such as hotels, transportation, schools, and other businesses.
PCT Corp. deploys its on-site production equipment under service contracts, charging an installation and set-up fee followed by monthly contract fees (some pricing models may include, or may be based on, a price per gallon of product used), over a contract period of approximately 3 – 5 years. The equipment is deployed and maintained through PCT Corp.’s personnel at first, then through specially-trained distributors. The Company is exploring the use of licensed commercial services companies to provide the future on-site support, as required. The product generators and other components of the on-site systems are currently monitored remotely by a PCT Corp. equipment specialist(s), but we are considering contracting with a monitoring company that is highly experienced and provides round the clock expertise in remote monitoring and response systems. The precise nature of any functional problems that may occur with any of the system’s components are, in most cases, automatically communicated via the internet to the monitoring and control center of the equipment. Any problem is then resolved through a three-tiered problem response system: first by remote access to the computerized system controls, second by an on-site technician call, and third through a “rapid replacement” program. If problems are not resolved by the first or second tier responses, then PCT Corp. would overnight ship replacement parts or, if necessary, a complete station or system and have the defective unit returned for repair.
FACTS not fiction
For years, many countries around the world have been reaping the benefits that HOCL brings to healthcare; food processing and manufacturing; water treatment; and water recycling, along with the improved hygiene standards it offers within the cleaning and housekeeping sectors. Outside the UK, the healthcare sector has used HOCL to help people breathe who have contracted COVID-19: one dying patient is reported to have recovered from pneumonia when HOCL was used to aid his breathing. HOCL is used for wound care applications like ulcerated wounds, for patients who have contracted an MRSA infection, or on diabetic skin ulcers. Wounds always heal faster when treated with HOCL, as it prevents biofilm from infecting the wound and fights off any airborne invaders that try to populate the wound.
https://www.healtheuropa.eu/can-hypochlorous-acid-revolutionise-hospital-cleaning/101602/
It changes nothing.
HOCL is the driving force.
HOCL must be applied first which is what kills the viruses. The coating just seals it.
What I question is if it seals it and the HOCL is within the seal, what happens if a virus gets on top of it.
It is also time consuming. One must fog twice.
This is a game changer in the disinfection industry. It is only allowed in Texas at the moment. I'm waiting for it to hit the EPA database to get more info. It is a private company out of Texas.
This is what the Germinator company was touting about continuous protection however they didn't have EPA approval.
Allied BioScience
SurfaceWise2 Becomes First Antiviral Surface Coating Approved By EPA To Continuously Protect Against COVID-19 With A Single Application.
SurfaceWise2 is the first and only surface protectant that is proven to continuously kill 99.9% of viruses including SARS-CoV-2, which causes COVID-19, within two hours.
Accordingly, this new emergency exemption represents the first time that EPA has approved the use of any antiviral product with long-lasting effect. The product, Allied BioScience’s “SurfaceWise 2,” contains the active ingredient 1-octadecanaminium,N,N-dimethyl-N[3-(trihydroxysilyl)propyl],chloride and is intended for use after a List N disinfectant has already been applied. Under the exemption, the state of Texas is authorized to allow certain uses of SurfaceWise2 by American Airlines and Total Orthopedics Sports & Spine; the product is not yet available to the public, and application under the exemption is only allowed by trained and authorized users. When announcing the exemption, however, EPA also noted that it will soon release guidance to help disinfectant manufacturers pursue Agency approval of other antiviral surface coatings for the public.
It appears that they use HOCL and then apply their coating.
https://www.alliedbioscience.com/surfacewise/
Thanks for the breakdown.
You truly live up to your name.
The Annihilyzer is going places. Anytime one is leased or sold it will be talked about within that hospitals network and beyond. There are very few stand alone hospitals in the U.S.
I said it before and I'll say it again PCTL's flagship product the Annihilyzer (and large volume systems) was, is and will be the end game.
Can anyone explain why a hospital would have 7 Annihilyzer systems?
It doesn't matter because I'm confidant more orders are in the pipeline.
SNOWBALL EFFECT ACTIVE
I hope the company can keep up with upcoming orders.
PCTL is in a great position to disrupt the market share of contracts for Infection Control Systems with Healthcare and other industries.
Why did they focus on Healthcare first?
Hospital Disinfectant Products Market to Expand at Growth Rate of ~ 5.3% CAGR from 2018 to 2026 to Reach US$ 17.1 Billion through 2026:
https://www.prnewswire.com/news-releases/hospital-disinfectant-products-market-to-expand-at-growth-rate-of--5-3-cagr-from-2018-to-2026-to-reach-us-17-1-bn-through-2026-transparency-market-research-300999388.html
PCTL has the best solution to a multi-billion dollar problem.
Introducing the Most Technologically Advanced Disinfection System Ever Created to Eliminate Hospital Associated Infections (HAIs) using Patented RFID Technology for Tracking and Disinfecting Protocols.
Annihilyzer: A New Disruptive Technology in the World of Hospital Disinfection
Why is the Annihilyzer Infection Control System one of the best and most versatile in the world ?
The Annihilyzer System is truly a cost-effective Green Seal Certified end-to-end total facility disinfection and cleaning system. This system generates both a hospital grade disinfectant and a very effective cleaning solution to cover virtually all of your cleaning and disinfection needs. These on-site generators produce stable electrochemically activated solutions, OSG 460D - Hospital Grade Disinfectant that is effective against C. diff, MRSA, and VRE, and an OSG 11-12 All Purpose Cleaner, and downtime for the process is only 15 - 20 minutes with no special preparation or precautions necessary.
The Annihilyzer System doesn't stop there, though. The icing on the cake is our state-of-the-art whole-room and handheld electrostatic sprayers that make quick work of completely disinfecting a room. Our 460D disinfectant can even be used to disinfect floors without leaving a haze or residue. We use a powerful non-synthetic disinfectant along with an automated electrostatic spray cart and/or electrostatic sprayers and patented RFID tracking technology that together are unmatched the industry to ensure proper and complete application.
What can the Annihilyzer do?
Save time and money by generating disinfectant and all-purpose cleaner on-site, on-demand
Eliminate the toughest bacteria, viruses, and fungi, including C. diff, C. auris, MRSA, VRE, blood-borne pathogens, and more.
Create 'industry best' protocols and 'push' them out to your cleaning staff in real-time with the Annihilist dashboard and mobile app
Generate reports that show when the areas were cleaned, who cleaned them, and what was done
Increase staff efficiency and effectiveness with process tracking, training, and accountability
How does the Annihilyzer save companies money?
Costs associated with purchasing and managing chemicals – eliminated
Freight charges for chemical deliveries – eliminated
Chemical container disposal or recycling costs – eliminated
Personal protection gear for cleaning – eliminated
Wastewater disposal costs and related fines for non-compliance – eliminated
Workers comp claims due to chemical burns and fume inhalation – eliminated
Happier, healthier and more productive workers
Same or better cleaning power than traditional hazardous chemicals for less
Eliminates costs associated with ordering, inventorying and disposing of chemicals and containers
Versatile
Grieco added: “All of our hospital customers using our infection control system and disinfectant are utilising the systems as a front-line defence throughout their facilities, including in all public area such as restrooms, lobbies, waiting rooms, elevators, corridors, cafeterias, etc. all throughout the day and night and in the presence of patients, staff and visitors.”
What other Infection Control System can do that?
What other system can provide a disinfectant and cleaner?
Results
Why would a hospital sign a 5-year agreement with PCTL when they could have signed a 2 or 3 year agreement?
I'll tell you why - RESULTS RESULTS RESULTS
SUNY Downstate Medical Center chose to renew their contract with the Company for an additional five years after utilizing the system for one year.
What are the chances at some point in the future when the other SUNY hospitals (Syracuse and Stony Brook) Infection Control Contracts expire that they sign with PCTL?
Why has every hospital that went through the 60 day trial period decided to do a multi-year contract? I'll tell you why - RESULTS RESULTS RESULTS
How many hospitals are in NYC?
There are 62 acute care hospitals in New York City.
How many hospitals in NYC have at least one Annihilyzer System?
PCTL has installed at least 19 systems and gained 22.5% market share in NYC hospitals in less than 18 months.
Most Technologically Advanced Disinfection System Ever Created
Annihilyzer the future for Healthcare and other Industries
During the Coronavirus Pandemic a Hospital with the Annihilyzer in place was in a better position than a hospital without it. Many hospitals will be asking themselves what could we have done differently? If they know about the Annihilyzer, having one will certainly be one of their answers. This is not the last one so they have to put themselves in the best position for future events.
What is a better investment for a whole room Infection Control System:
Annihilyzer versus an UV system?
They both disinfect effectively however the Annihilyzer provides an additional products, an all purpose cleaner and handheld electrostatic sprayers that can be used in other parts of the hospital in the presence of people because it is “Green Certified”.
Also the Annihilyzer cost less than half that of one of the best UV system on the market, the Xenex “LightStrike” cost about $125,000,
Annihilyzer versus a Chemical (Hydrogen Peroxide) based system?
They both disinfect effectively however the Annihilyzer provides an additional products, an all purpose cleaner and handheld electrostatic sprayers that can be used in other parts of the hospital in the presence of people because it is “Green Certified”.
Chemical based solutions require protective equipment, are more expensive and are harsh on furniture and one company called Hanosil sells their machine for under $10,000 however it costs $20 in product to clean each room.
Top 10 largest health systems by member hospitals
HCA Healthcare: 214
CommonSpirit Health: 197.
Universal Health Services: 170.
Department of Veterans Affairs: 162.
Encompass Health Corporation: 123.
Ascension Health: 117.
Select Medical Corporation: 113.
Community Health Systems: 100.
Tenet Healthcare: 87
LifePoint Health: 86
Health systems, also referred to as integrated delivery networks (IDNs), are networks of providers and care facilities that are formed with the goal of improving clinical and quality performance. IDNs help to ensure that patients receive the best care outcomes for the lowest costs, and usually offer a full range of healthcare services from preventative to post-acute care.
Each health system is different in terms of size, specialty, and membership makeup. According to Definitive Healthcare data, approximately 78 percent of hospitals belong to an IDN—up from 75 percent in 2018.
Top 10 health systems by net patient revenue
HCA Healthcare: $42,673,974,296
Kaiser Permanente: $29,176,611,660
CommonSpirit Health: $28,358,722,418
Ascension Health: $18,788,901,219
Providence St. Joseph Health: $16,286,062,476
Kaiser Permanente Northern California: $14,359,957,345
Tenet Healthcare: $14,140,396,155
Kaiser Permanente Southern California: $14,011,636,037
Trinity Health: $13,737,577,562
University of California Health: $13,032,563,332
The top health systems listed here reported a combined net patient revenue of over $204 billion as of July 2020—making these networks a lucrative sales and marketing opportunity for organizations selling into the healthcare market.
Large IDNs like HCA Healthcare, Kaiser Permanente, and others often act as group purchasing organizations (GPOs) for their member hospitals. This means that the health systems negotiate with vendors to receive lower prices for supplies and services. According to Definitive Healthcare data, about 93 percent of U.S. hospitals are affiliated with a GPO—up from 84 percent in 2019.
By understanding the pricing structures achieved by GPOs, an IDN may be able to further negotiate on behalf of its member facilities. Additionally, many IDNs service a local region, giving them a unique ability to identify the needs of a defined community and address pricing needs accordingly, in a way that nationwide IDNs or GPOs may be unable to match.
Collectively, the largest health systems manage more than 1,300 hospitals—nearly 20 percent of active hospitals in the United States. This could give these hospitals an advantage in lowering care costs. In addition to negotiating purchasing prices, health systems also help to keep patient referrals in-network. This improves care coordination, enhances the patient experience, and prevents revenue loss by referring outside of a hospital's network.
https://blog.definitivehc.com/top-10-largest-health-systems
It already happened in NYC where hospitals in the same network leased Annihilyzers.
PCTL business in the U.S. is bigger than whatever will happen in the UK.
We are currently waiting on system orders decisions from 3 hospital networks from 3 different states, upstate NY, CT and TN.
It already has been tested and proven to work.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158025945
Through PCTL’s primary healthcare distributor, ACE Janitorial Services, five (5) of the company’s modified rack-mounted Annihilyzer® Infection Control systems are being installed at an existing NYC hospital, adding to the two systems currently installed and operating at this location. The hospital is currently conducting a pilot program aimed at increasing their ability to produce disinfecting fluid onsite for use in multiple applications.
Seven (7) systems in one hospital is huge. The first 2 systems is probably used for disinfecting rooms and cleaning. The other 5 systems is for a pilot program for what?
I've stumble into this article that may possibly be the answer:
A Modern Approach to Disinfection, as Old as the Evolution of Vertebrates
The immune system of vertebrates “naturally” produces hypochlorous acid (HOCl) to fight against bacteria and pathogens. A patented electrochemical technology mirrors the above defense system, allowing the synthesis of HOCl solutions through the electrolysis of water enriched in salts, at the level of a few grams per liter. The system allows for the careful control of the pH of produced solutions, with consequent optimization of their activity. Once the HOCl is introduced into the water system; it is able to remove the biofilm from pipe network; significantly decreasing the level of Legionella colonization; within 8–10 weeks from the beginning of the disinfection approach. The technology has been applied in a variety of healthcare facilities, both in Italy and in neighboring European countries. In the present paper, two successful case studies are briefly presented: Data were obtained from experiences in two different healthcare facilities, one in Italy and the other in Germany. Destruction of biofilm was indirectly testified by an increase of total organic carbon content of water; as a consequence, and because of the dosing of the disinfecting agent, some µg/L of total halomethanes were also formed. However, both compositional features were only observed during the initial stages of the disinfection treatment.
3.1. Decontamination of Hot Water System — Dresden University Hospital (Germany)
At the beginning of the monitoring program (see Table 1), analyses showed a systemic colonization of the hot water network of the department of Neurology: Colony counts of Legionella pneumophila were repeatedly over 10,000 CFU/L. Within a week from the installation of the HOCl generating unit, a significant reduction in colony counts of L. pneumophila at water outlets was achieved. Colony counts increased slightly afterwards, plausibly because of the destruction of biofilm. However, the contamination completely disappeared after about 8 weeks. No Legionella was detected 6 months later during the manufacturer’s recommended inspection. Technical problems such as corrosion or leaching of the piping were not reported. During the first 8 weeks, chemical analyses have determined that the chlorine content in tap water did not exceed 0.6 mg/L. Actually, the German regulation allows a chlorine content in drinking water up to 1.2 mg/L at the injection point, and between 0.1 and 0.3 mg/L at the points of use; exceptionally, the chlorine concentration can be raised up to 0.6 mg/L [21,26]. Patients and staff tolerated the temporary slightly higher chlorine smell.
3.2. Evaluation of Two Disinfection Systems for Legionella Eradication — Cardinal Massaia Hospital, Asti (Italy)
Method 1 proved to be effective in eradicating Legionella from the hospital water supply, with active chlorine concentration > 0.2 mg/L (the Italian legislation suggests a level of 0.2–0.3 mg/L at the point of use [27]). In contrast, method 2 was not efficient, at least at the biocide concentration proposed by the manufacturer. After the six-months research at one of the twelve hot-water circuits of the large Hospital of Asti, the medical management decided to install the anolyte-producing unit on all hot-water systems and units were installed in all buildings in October-November 2009. Results shown in Figure 2 refer to the first months of operation of the system (the chart legend reports the code of the rooms from where the samples were taken). From 2010 onwards, trends are actually straight lines connecting colony count data comprised between 50 and 100 CFU/L. Occasional rises (never exceeding 300 CFU/L) coincided with maintenance or extended periods of non-utilization [28].
Legionnaires' Hiding in Hospital Plumbing Systems
Deadly Legionnaires' disease is lurking in the water systems of hospitals, nursing homes and long-term care facilities, putting the most vulnerable patients at risk, U.S. health officials said Tuesday.
About 10 percent of people who get Legionnaires' disease die from it, but in health care facilities the death rate is higher -- 25 percent of those patients die if they get the disease, according to a new report from the U.S. Centers for Disease Control and Prevention.
"Legionnaires' disease in health care facilities is widespread, deadly and preventable," CDC Acting Director Dr. Anne Schuchat said during a noon press briefing Tuesday.
Despite the CDC's efforts to get health care facilities to develop effective water management programs, more is needed to protect patients from this deadly bacteria, she said.
Legionnaires' disease is a serious lung infection that causes pneumonia. People can get it by breathing in small droplets of water containing the Legionella bacteria.
The bacteria thrives in building water systems that are not adequately managed and where disinfectant levels are low, water is stagnant, or water temperatures are warm, Schuchat said.
Most healthy people do not get Legionnaires' disease after exposure to the bacteria, she said. People most at risk are those aged 50 or older or those who have other risk factors, such as being a current or former smoker, having a chronic disease or having a weakened immune system, Schuchat said.
"People can inhale the bacteria from small water droplets from showers, water therapy spas, baths, cooling towers, decorative fountains and medical equipment, like respiratory therapy equipment," she said.
Legionnaires' disease in health care facilities is costly, Schuchat added. In one year alone, insurance companies paid out an estimated $434 million for claims arising from Legionnaires' disease infection, and total health care costs per patient averaged about $38,000, she said.
The problem is probably bigger than the report's figures indicate. "It's just the tip of the iceberg," Schuchat noted. Most cases of Legionnaires' disease in health care facilities go unreported because patients who develop pneumonia aren't routinely tested for Legionnaires', she explained.
For the report, CDC researchers analyzed 2015 data from 21 areas around the country and found that 76 percent of reported cases of Legionnaires' disease were linked to health care facilities.
During 2015, approximately 6,000 cases of Legionnaires' disease were reported to CDC, but only about half included where the infection was acquired.
The findings in this new report are based on data from 20 states and New York City, where how the infection was acquired was recorded.
Earlier this month, the U.S. Centers for Medicare and Medicaid Services (CMS) alerted health care facilities that they are now expected to develop and adhere to policies and procedures to reduce the risk of Legionella and other waterborne germs, Schuchat said.
These procedures will be part of future inspections conducted by the CMS, she said.
Dr. Marc Siegel, a professor of medicine at NYU Langone Medical Center in New York City, said, "This is all about improper maintenance, improper sanitation and improper sterilization, and a vastly underreported problem."
Doctors should be on the lookout for Legionnaires' disease in patients who develop pneumonia, he said.
Siegel added that the building itself, including its water system, is part of the biosphere of the facility and needs to be as sterile as possible to prevent Legionnaires' disease.
https://www.webmd.com/lung/news/20170606/legionnaires-hiding-in-hospital-nursing-home-plumbing-systems-cdc
That is the nature of business.
We are a supplier that sell at at a wholesale price and the distributor can sell at whatever price they desire. Also if they make byproducts using HOCL, they can make even more money. Our revenues will continue to grow as the distributors grow and through the leasing of our equipment both of which have been increasing in recent months.
Here is our per gallon pricing:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154647600
Through PCTL’s primary healthcare distributor, ACE Janitorial Services, five (5) of the company’s modified rack-mounted Annihilyzer® Infection Control systems are being installed at an existing NYC hospital, adding to the two systems currently installed and operating at this location. The hospital is currently conducting a pilot program aimed at increasing their ability to produce disinfecting fluid onsite for use in multiple applications.
Seven (7) systems in one hospital is huge. The first 2 systems is probably used for disinfecting rooms and cleaning. The other 5 systems is for a pilot program for what?
I've stumble into this article that may possibly be the answer:
A Modern Approach to Disinfection, as Old as the Evolution of Vertebrates
The immune system of vertebrates “naturally” produces hypochlorous acid (HOCl) to fight against bacteria and pathogens. A patented electrochemical technology mirrors the above defense system, allowing the synthesis of HOCl solutions through the electrolysis of water enriched in salts, at the level of a few grams per liter. The system allows for the careful control of the pH of produced solutions, with consequent optimization of their activity. Once the HOCl is introduced into the water system; it is able to remove the biofilm from pipe network; significantly decreasing the level of Legionella colonization; within 8–10 weeks from the beginning of the disinfection approach. The technology has been applied in a variety of healthcare facilities, both in Italy and in neighboring European countries. In the present paper, two successful case studies are briefly presented: Data were obtained from experiences in two different healthcare facilities, one in Italy and the other in Germany. Destruction of biofilm was indirectly testified by an increase of total organic carbon content of water; as a consequence, and because of the dosing of the disinfecting agent, some µg/L of total halomethanes were also formed. However, both compositional features were only observed during the initial stages of the disinfection treatment.
Different approaches are currently being used to fight against opportunistic pathogens present in aquatic environments, such as Legionella. Since each method has some pros and, unfortunately, some cons, a universally applicable solution has not been identified yet. The approach described in this study was inspired by observing how the immune system of vertebrates works to defend the body from any form of chemical, traumatic or infectious insult to its integrity (see e.g., [1]). Nonspecific immunity is substantially based on the activity of neutrophils and macrophages leukocytes, which have the fundamental task to capture and destroy foreign substances, through phagocytosis. Of great importance is the action of myeloperoxidase (MPO), an enzyme that produces hypochlorous acid (HOCl) from hydrogen peroxide (H2O2) and chloride anion (Cl-), during the neutrophils’ respiratory burst [2,3,4].
University Hospital of Dresden, Dresden, Germany. Due to the positioning of the buildings in a pavilion system, the Dresden University Hospital has used several different hot water systems decontamination methods. Besides the electrolytic process presently under discussion, thermal disinfection, a combination of UV with ultrasound or the filtration of drinking water at the point of use have all been used. Despite several thermal decontaminations, colony counts of Legionella pneumophila in the hot water system of the department of neurology were repeatedly over 10,000 colony-forming units (CFU)/L. Isolates were determined to belong to several serogroups, including serogroup 1 that is associated with a higher virulence. A two-story building of 15 years with 45 beds was selected to assess the performance of the Ecas technology.
Cardinal Massaia Hospital, Asti, Italy. The Asti hospital is organized in six departments, for a total of 471 beds for inpatient admissions and 51 places for day-hospital. In addition, a surgical unit with 11 rooms, a block of Day Surgery and an obstetric room are located on the -1, 2nd and 3rd floor, respectively. The total area of the Asti hospital amounts to 125,000 m2; the daily average attendance is about 450 patients, and the employment index is equal to 90%. Nosocomial infections are prevented by using control measures against Legionella proliferation in the hot water distribution system. The plant is divided into several sub-stations: Each one consists of a heat exchanger, fed by water at 90 °C coming from the main heating plant, 11 vertical tanks and 1 horizontal tank in galvanized steel, internally coated with Teflon. The distribution plant consists of a recirculation loop, in order to keep an optimal temperature in the vicinity of the different peripheral points. The cold water pertaining to the hot water system network is softened at 4 °f. In general, a complete elimination of bacteria is difficult to achieve with any disinfection approach. In this study, the efficacy of two continuous dosing methods for the eradication of Legionella from hospital water supplies has been evaluated and compared. Both approaches require the continuous dosing of a biocide into the hot water system: Method 1 involves the use of an electrochemically activated water (the Ecas anolyte), containing hypochlorous acid at neutral pH, while method 2 relies upon a solution of hydrogen peroxide and silver (Cillit Allsil Super 25 Ag). It is worth mentioning that the latter approach is not always applicable, being for example not permitted by German legislation for continuous treatment of drinking water [21]. The two continuous disinfection systems were installed in the Asti hospital in two distinct water supplies.
3.1. Decontamination of Hot Water System — Dresden University Hospital (Germany)
At the beginning of the monitoring program (see Table 1), analyses showed a systemic colonization of the hot water network of the department of Neurology: Colony counts of Legionella pneumophila were repeatedly over 10,000 CFU/L. Within a week from the installation of the HOCl generating unit, a significant reduction in colony counts of L. pneumophila at water outlets was achieved. Colony counts increased slightly afterwards, plausibly because of the destruction of biofilm. However, the contamination completely disappeared after about 8 weeks. No Legionella was detected 6 months later during the manufacturer’s recommended inspection. Technical problems such as corrosion or leaching of the piping were not reported. During the first 8 weeks, chemical analyses have determined that the chlorine content in tap water did not exceed 0.6 mg/L. Actually, the German regulation allows a chlorine content in drinking water up to 1.2 mg/L at the injection point, and between 0.1 and 0.3 mg/L at the points of use; exceptionally, the chlorine concentration can be raised up to 0.6 mg/L [21,26]. Patients and staff tolerated the temporary slightly higher chlorine smell.
3.2. Evaluation of Two Disinfection Systems for Legionella Eradication — Cardinal Massaia Hospital, Asti (Italy)
Pre-treatment samples from water supply 1 showed Legionella contamination of 60–180 CFU/L in the hot water tank, and of 300–16,000 CFU/L in distal points. After starting the anolyte-based disinfection system (method 1: Dosing of active chlorine was between 1.2 and 0.3 mg/L, mean 0.6 mg/L), all samples showed a clear reduction in colony counts (≤100 CFU/L). Samples from water supply 2 showed initial contaminations in the range 180–24,000 CFU/L. After starting the disinfection, by dosing 2 mg/L of hydrogen peroxide (method 2), the contamination reduced to 20–15,000 CFU/L. During the observation period, the product was dosed at variable concentrations and only in the second-last sampling, in the presence of the highest dose of biocide (>25 mg/L), the culture counts were negative. However, the contamination appeared again in the last sampling (H2O2 at 2 mg/L), with values up to 600 CFU/L.
Method 1 proved to be effective in eradicating Legionella from the hospital water supply, with active chlorine concentration > 0.2 mg/L (the Italian legislation suggests a level of 0.2–0.3 mg/L at the point of use [27]). In contrast, method 2 was not efficient, at least at the biocide concentration proposed by the manufacturer. After the six-months research at one of the twelve hot-water circuits of the large Hospital of Asti, the medical management decided to install the anolyte-producing unit on all hot-water systems and units were installed in all buildings in October-November 2009. Results shown in Figure 2 refer to the first months of operation of the system (the chart legend reports the code of the rooms from where the samples were taken). From 2010 onwards, trends are actually straight lines connecting colony count data comprised between 50 and 100 CFU/L. Occasional rises (never exceeding 300 CFU/L) coincided with maintenance or extended periods of non-utilization [28].
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934573/
If it is not for the water system then the air handling units may be another possibility.
John Ware, Director of Envirolyte ECA UK Ltd, details how the Envirolyte disinfection product can aid in the fight against COVID-19.
The arrival of the coronavirus created an enormous amount of interest in Envirolyte hypochlorous acid (HOCL) as a disinfection product, to see if it could be used within a wider prevention and protection strategy to help reduce the spread of COVID-19.
For years, many countries around the world have been reaping the benefits that HOCL brings to healthcare; food processing and manufacturing; water treatment; and water recycling, along with the improved hygiene standards it offers within the cleaning and housekeeping sectors. Outside the UK, the healthcare sector has used HOCL to help people breathe who have contracted COVID-19: one dying patient is reported to have recovered from pneumonia when HOCL was used to aid his breathing. HOCL is used for wound care applications like ulcerated wounds, for patients who have contracted an MRSA infection, or on diabetic skin ulcers. Wounds always heal faster when treated with HOCL, as it prevents biofilm from infecting the wound and fights off any airborne invaders that try to populate the wound.
Sadly, here in the UK we have been very slow to adopt electrolysed water technology for patient treatments or as a replacement for sodium hypochlorite (SH), which is an irritant and is corrosive, necessitating the use of PPE. SH is used for many housekeeping, clean up and disinfection applications within wards to clear up blood, faeces, or contamination incidents. HOCL is able to provide safe and superior disinfection capabilities for any tasks that SH is already used for; and can be safely used without PPE, although we recommend that nursing staff follow their hospital’s health and safety recommendations for using PPE with the individual chemical products. Anolyte ANK, our HOCL liquid, is used against COVID-19 by spraying surfaces; it can be dry fogged within occupied working environments, or even used within decontamination tunnels or chambers to disinfect people who are entering or leaving work.
Now that the WHO has finally accepted that the COVID-19 is an airborne threat, and that it is not just transmitted by droplets, our belief is that we need a long term set of protocols to ensure we have a comprehensive prevention and protection strategy in place, both at work and when using public transport like trains, buses, aeroplanes or even cruise ships. Heating, ventilation, and air conditioning (HVAC) systems in buildings will have to be adapted to ensure that COVID-19 is prevented from entering through the outside air inlet vents. It must be prevented from entering any associated office areas that are connected to air handling units (AHUs) or ventilation ductwork systems. Return air from internal spaces which is either exhausted to the outside of the building or recirculated must be prevented from allowing COVID-19 to pass back into and mix with the supply air; all the air entering a building must be treated using a method of disinfection.
There is a belief that high efficiency particulate air (HEPA) filters can be fitted to AHU systems to help remove viruses; although this might seem a good idea, AHU fans cannot always be retrofitted to overcome the resistance that the HEPA filters produce. If they were fitted, the airflow duty produced by the fan would be significantly reduced, which would in turn reduce the heating and cooling capacity that the system is designed to offer at peak winter and summer periods.
As I spent many of my younger years working within the HVAC sector, I am well aware of all the issues that must be overcome to help combat our battle against COVID-19. By implementing the use of Anolyte ANK we can help with AHU systems by fogging the supply air with our HOCL, which will provide disinfection against COVID-19 and any other airborne pathogens, bacteria or viruses that are within the airstream. Providing good quality air which is free from harmful microorganisms or viruses can only benefit the occupants within an air conditioned or ventilated building. Good quality air prevents the occurrence of ‘Sick Building Syndrome’.
During this pandemic we have been fogging, but on a smaller scale; by using desktop fogging units within workplaces, offices, schools, hairdressers and dental surgeries, to name but a few applications where people have benefited from the use of our non-toxic HOCL, which can be safely breathed in over the course of a working day. The safety our HOCL product offers can be clearly seen within our safety data sheet: it is unique when compared to the many other chemicals within the market, as the safety data will clearly show.
Envirolyte ECA UK Ltd is a BPR-compliant company that produces HOCL at 500ppm. We sell and supply the product to our sub-distributors and direct to end users, as well as offering white label products for companies.
Many of our competitors are supplying HOCL products into the marketplace at a lower ppm than ours, which is at 500 ppm. A large majority supply at 100 to 200 ppm to fight COVID-19; they also supply the dental market, but at high prices, whereas we can supply our superior product at a more competitive price and with a concentration that is 2.5 to five times the strength of theirs. A higher ppm product will allow you to use less HOCL and it will always disinfect quicker than one with a lower ppm – so why prolong the disinfection time? Reduce it by using our Envirolyte HOCL product, Anolyte ANK.
As the UK distributor, we also sell the complete range of Envirolyte machines, manufactured in Estonia: they use electrochemical activation (ECA) to generate the hypochlorous acid. This electrolysed water disinfection product has a free available chlorine (FAC) strength of 500ppm within a neutral pH range of six to seven. It is a green, safe, environmentally friendly and fully biodegradable liquid which acts as a very powerful antimicrobial and sterilising solution; and which conforms to the European Biocidal Products Regulation (BPR, Regulation (EU) No 528/2012) and is listed with the ECHA. It also holds NSF/ANSI 61 certification, which ensures that Envirolyte products meet the regulatory requirements for the US and Canada; it can often meet or fulfil testing requirements for many other countries.
https://www.healtheuropa.eu/can-hypochlorous-acid-revolutionise-hospital-cleaning/101602/
Now that the Q has dropped we should see some updates in many areas:
1. UK
2. Results from the consultant who has been on the job for almost 2 months.
3. Updates from the upstate NY, CT and TN system orders.
Also does anyone have thoughts on why a hospital would have 7 machines:
Through PCTL’s primary healthcare distributor, ACE Janitorial Services, five (5) of the company’s modified rack-mounted Annihilyzer® Infection Control systems are being installed at an existing NYC hospital, adding to the two systems currently installed and operating at this location. The hospital is currently conducting a pilot program aimed at increasing their ability to produce disinfecting fluid onsite for use in multiple applications.
That is a hell of a Pilot Program.
I wonder what the multiple applications is for
A lot of fluid can be produced with 7 machines,
If the pilot program is successful maybe other hospitals will replicate.
Interesting very interesting
It is all about pricing.
We sell to Level 1 and 2 at a certain price depending on quantity and they sell at a much higher price.
So if we are selling to a level 2 for $10 a gallon and they turn around and sell at $50 a gallon.
The only way we make mucho dinero is to increase our volume of sales (or raise prices) and that is exactly what PCTL is doing by adding more and more distributors.
Snow,
What progress were you expecting and why?
I believe that is the total debt they reduce through cash and stock sells.
If you look at the notes payable, notes payable related parties and the convertible notes payable tables it will show what was paid.
The bottom line is debt was reduce not by a whole lot however every little bit counts and PCTL is headed in the right direction by reducing debt.
PCTL’s footprint in the UK:
LITTLE RIVER, S.C., October 22, 2019 -- PCT LTD (OTC Pink: PCTL), a Little River, South Carolina company and the designer of the Annihilyzer® Infection Control System, a world class whole room cleaning and disinfecting system for hospitals and health care facilities, is pleased to announce that it has shipped the first overseas Annihilyzer® Infection Control System to its partner company, PCT Europe Ltd., in the United Kingdom.
The phase one installation will begin in November at a large 500 bed hospital in England. Upon successful completion of this initial installation, a continuing flow of orders from associated UK hospitals is expected during 2020.
https://www.para-con.com/images/docs/PCTL10-22-19.pdf
Little River, South Carolina — (April 16, 2020) – PCT LTD (OTC Pink: PCTL) is pleased to announce new growth and expansion activities in the UK and NYC. PCT Europe Ltd, the UKbased partner of PCTL is pleased to announce they have signed an exclusive trading partnership/distributor agreement with an NHS (U.K. National Health Service) company.
In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf
Little River, South Carolina — (May 29, 2020) – PCT LTD (OTC Pink: PCTL) is pleased to announce they have reached a final agreement with Paradigm Convergence Technologies (Europe) Ltd. The agreement was enacted on May 25th, 2020 and will secure a mutually beneficial business relationship between the two entities, in which PCTL will hold a beneficial stake.
“We have been working diligently to formalize the final terms of our arrangement,” says PCTL CEO Gary Grieco. “Through this agreement Paradigm Convergence Technologies (Europe) Ltd will be able to introduce our technology throughout the United Kingdom and their interconnected healthcare system.” The arrangement also provides territory rights to PCT Europe throughout 5 additional European nations.
“We see a growing need for our technology in the UK and throughout Europe, both in the short and long-term,” explains Grieco. “The highly talented team PCT Europe has in place will spearhead sales and placements in their respective territories and should result in a highly lucrative and beneficial arrangement for both parties.”
https://www.para-con.com/images/docs/PCTL05-29-20.pdf
NTH Solutions was established in April 2018 to provide estates, facilities and support services to North Tees and Hartlepool NHS Foundation Trust. With our 700 strong workforce we also supply those services into the surrounding community. The income generated by this enables the Trust to reinvest in front line patient care.
Stockton-based NTH Solutions, an NHS subsidiary company owned by North Tees and Hartlepool NHS Foundation Trust, has appointed experienced decontamination manager, Tony Sullivan, following an increased demand for infection control services due to the Covid-19 pandemic.
NTH Solutions has partnered with PCT Europe to launch its revolutionary, decontamination solutions to support organisations across the UK with their infection control and deep cleaning.
Revolutionary decontamination technology from an NHS owned company. The eco-friendly decontamination solution that kills 99.9999% of HAI pathogens.
Forget the harsh, toxic chemicals used in many conventional cleaning products. Our unique solution is no more harmful than water, requiring only electrolysed salt and water to produce two highly effective cleaning products – an antimicrobial disinfectant and a degreasing solution.
Why our solution to daily deep cleaning is completely unique
Kills 99.9999% of known Hospital Associated Infection (HAI) pathogens
PH neutral means it’s no more harmful than water
Environmentally friendly infection control
NHS training comes as standard
No chemical stabilisers like other HOCl products on the market
Supporting the NHS and enabling reinvestment into frontline patient care
A safe and cost-effective solution
As an NHS owned organisation, we are always looking at ways to reduce costs without compromising on safety and efficiency of our products. PCT’s solution has offered us a cost-effective alternative to conventional cleaning products, while still prioritising the safety and wellbeing of our staff and patients.
I have felt more empowered as a ward hygienist since we introduced PCT’s disinfectant and degreaser into my cleaning routine. Investing in the new technology has undoubtedly improved the efficiency of my day-to-day tasks and has given me the peace of mind that the products I use are safe.
Most emerging growth companies are.
PCTL is at a crossroad of bringing their flagship product, the Annihilyzer to the market and the sales has been increasing gradually in recent months:
On or about June 17, 2020 PCTL had at least 25 Annihilyzers in 25 different hospitals.
Since then?
At least 10 more system installs on the Horizon:
Following up on an earlier release, a system installation was performed for an existing hospital
client in NYC through PCTL’s primary healthcare distributor, ACE Janitorial Services. This installation was completed in mid-June, the last of three scheduled installations mentioned in an April 14th press release. The other two installations mentioned in the same announcement were completed and mentioned in a release on May 8th of this year.
Additional and ongoing activities in the US Healthcare market include, but are not limited to:
Installation of 5 additional systems with an existing NYC Hospital client.
Pending final approval for an additional installation of two systems at a third, existing NYC Hospital client.
In the quoting phase, an additional system order is pending approval for a large hospital network in upstate New York.
In the quoting phase, an additional system order is pending approval for a large hospital network in Connecticut.
In the quoting phase, an additional system order is pending approval for a large hospital network in Tennessee.
System orders which have reached the quoting phase, barring any unforeseen restrictions or difficulties, should receive final approval and be installed within 30-60 days. Existing healthcare clients awaiting final approval should see installations commence within 30-60 days.
Hopefully the system orders in the quoting phase will be done before the end of the quarter.
I would imagine PCTL is very busy building systems as 5 are needing now and 2 are awaiting final approval. I suspect the systems orders for upstate New York, Connecticut and Tennessee will be for multiple systems as they are hospitals networks not single hospitals.
This is certainly a sign of a growing company on the move to becoming more successful with many different avenues and systems configurations to get there per 2019 10K:
Annihilyzer Infection Control System – Hospital/Healthcare
Annihilyzer Infection Control System – Rack Model
Hydrolyte Generator – Large and Medium Volume
SurvivaLyte Manual Generator – Small Volume
Annihilyzer Hospital 360 SMART Spray Cart
School/Hospitality Industry and General Business 360 SMART Spray Cart
Other models of Hydrolyte® generating equipment are in research and development.
Markets: The primary applications for the Hydrolyte® technology are in cleaning, sanitizing, and disinfecting in a variety of market sectors and settings, including:
Institutional facilities, such as hospitals, nursing homes, hotels, correctional facilities and schools;
The agriculture industry for pre- and post-harvest disinfection of crops, sanitization in food processing, and certain applications in animal husbandry;
The oil and gas industry where Hydrolyte® can provide a process to disinfect water used in hydraulic fracking processes (“frac water”) and to kill sulfate reducing bacteria in “sour” oil and gas wells; and Catholyte can be used to clean equipment and aid in product recovery when applied “down hole”; and.
Other potential market opportunities are available, e.g., disinfecting and sanitizing of water in public and private water systems and industrial waste-water systems.
Management determined that the most direct paths to rapid revenue and earnings growth are in the institutional facilities and agriculture markets, although the agricultural market present some EPA-related barriers. The preponderance of business development and marketing resources are currently being devoted to these two markets. Management intends to also work to maintain our position and expertise in the oil and gas industry to assure that current customer relationships are maintained, business opportunities at hand are pursued and that we are properly positioned for a roll-out as, and when, drilling activity increases as anticipated. As further market development occurs, the Company anticipates considering and acting upon factual information.
Institutional Facilities: Hospitals, Health Care Facilities & Schools
PCT Corp.’s senior research and development personnel have developed several models of equipment to be deployed as a state-of-the-art integrated product dispensing, tracking (patented RFID tracking features) and management systems for applications in the institutional facilities market. This integrated technologies solution, branded as PCT’s Annihilyzer® Infection Control System, has been designed most particularly for hospitals, large long-term care, assisted living and nursing home facilities. In various configurations (utilizing a rack model) it in can be deployed in other health care facilities including urgent care centers, medical, dental and veterinary offices. It is adaptable to deployment in schools, prisons, hotels, and many other facilities, although the primary marketing and sales goal for PCT Corp. remains with the hospital market. A complete and custom turn-key cleaning and disinfection program solution can be provided to each facility.
The Company created and offers a proprietary automated state-of-the-art Electrostatic Spray Cart for use in hospital (or hospitality-industry) settings, allowing for rapid disinfecting of rooms once a patient (guest) has vacated the room. This system is designed to reduce the turnover time required between patients/guests, potentially increasing revenue opportunities, and improving efficiency of hospital/hotel personnel. A smaller scaled model of the electrostatic spray cart is available to other industries, such as hotels, transportation, schools, and other businesses.
PCT Corp. deploys its on-site production equipment under service contracts, charging an installation and set-up fee followed by monthly contract fees (some pricing models may include, or may be based on, a price per gallon of product used), over a contract period of approximately 3 – 5 years. The equipment is deployed and maintained through PCT Corp.’s personnel at first, then through specially-trained distributors. The Company is exploring the use of licensed commercial services companies to provide the future on-site support, as required. The product generators and other components of the on-site systems are currently monitored remotely by a PCT Corp. equipment specialist(s), but we are considering contracting with a monitoring company that is highly experienced and provides round the clock expertise in remote monitoring and response systems. The precise nature of any functional problems that may occur with any of the system’s components are, in most cases, automatically communicated via the internet to the monitoring and control center of the equipment. Any problem is then resolved through a three-tiered problem response system: first by remote access to the computerized system controls, second by an on-site technician call, and third through a “rapid replacement” program. If problems are not resolved by the first or second tier responses, then PCT Corp. would overnight ship replacement parts or, if necessary, a complete station or system and have the defective unit returned for repair.
This is the PCTL board where our company don't lie about the capabilities of it's products.
PCTL’s mission, ambition, plan was, is and will be the Annihilyzer.
PCT LTD focuses its business on sustainable, environmentally safe technologies and products. The company acquires, holds and develops rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp) .
The business mission of PCT Corp. is to profitably provide Electro-Chemical Activation equipment and disinfecting fluid solutions to hospitals for the documentable prevention of Healthcare Associated Infections (HAI’s). PCT Corp. designs, develops, integrates, assembles and commercializes technologies, products and systems targeted at the prevention and control of infectious disease. Its unique and patented systems and human-safe products provide next-generation cleaning, sanitizing, and disinfecting.
A NEW DISRUPTIVE TECHNOLOGY IN THE
WORLD OF HOSPITAL DISINFECTION
defeating HAIs with science not chemicals
Healthcare Associated Infections (HAI) — also known as a nosocomial infection are transmitted within a healthcare facility from patient to patient. It can be spread throughout the hospital environment, nursing home environment, rehabilitation facility, clinic, or other clinical settings resulting in a 35 billion dollar a year problem. HAI’s include C-Diff, Staph, MRSA, …. With our system, not only can we reduce harmful bacteria but we can also help you drastically reduce the financial liability associated with HAI and improve your bottom line savings, by increasing efficiency, reporting, and cutting down on labor and harmful chemical costs.
The expansion of Hypoclorous Acid was a gift that has allowed PCTL to execute the build out of Annihilyzer systems.
HAPPENING RIGHT NOW
While we are in a Pandemic many organizations especially Hospitals are asking themselves what could we have done and can do to better protect ourselves and clients during this and possible future events.
I would be astonished if the Annihilyzer doesn’t come up in a lot of these conversations especially as different organizations start to compare notes. I have written many messages of the effectiveness of the Annihilyzer as to why it is superior to other systems not only in defeating pathogens, but price wise and the fact it is green would bring additional cost savings.
Make no mistake the end game is the Annihilyzer and other HOCI producing systems.
"Our technology does to the chemical industry what UBER did to the transportation industry.”
FACTS not fiction
The problem selling to big retail chains from Little River, SC is shipping which would drive up costs. The distributors could sell to local chains. That being said the if the company had a marketing campaign telling the world what they have and what it can do and directing them to the distributors that is very possible.
We do have a consultant however I don't know what he/she has been doing. I reached out to the company as to the progress. Hopefully we will hear something after the Q drops.
This is the consultant announcement from the 2020 1st 10Q NOTE 12. SUBSEQUENT EVENTS:
On July 8, 2020, the Company entered into a consulting agreement. Pursuant to the agreement the consultant will provide business development and introductory services for a period of five years in consideration for the issuance of 1,000,000 common shares of the Company and a 5% commission, paid in shares, for any investments brokered.
PCTL is in a great position to disrupt the market share of contracts for Infection Control Systems with Healthcare and other industries.
Why did they focus on Healthcare first?
Hospital Disinfectant Products Market to Expand at Growth Rate of ~ 5.3% CAGR from 2018 to 2026 to Reach US$ 17.1 Billion through 2026:
https://www.prnewswire.com/news-releases/hospital-disinfectant-products-market-to-expand-at-growth-rate-of--5-3-cagr-from-2018-to-2026-to-reach-us-17-1-bn-through-2026-transparency-market-research-300999388.html
PCTL has the best solution to a multi-billion dollar problem.
Introducing the Most Technologically Advanced Disinfection System Ever Created to Eliminate Hospital Associated Infections (HAIs) using Patented RFID Technology for Tracking and Disinfecting Protocols.
Annihilyzer: A New Disruptive Technology in the World of Hospital Disinfection
Why is the Annihilyzer Infection Control System one of the best and most versatile in the world ?
The Annihilyzer System is truly a cost-effective Green Seal Certified end-to-end total facility disinfection and cleaning system. This system generates both a hospital grade disinfectant and a very effective cleaning solution to cover virtually all of your cleaning and disinfection needs. These on-site generators produce stable electrochemically activated solutions, OSG 460D - Hospital Grade Disinfectant that is effective against C. diff, MRSA, and VRE, and an OSG 11-12 All Purpose Cleaner, and downtime for the process is only 15 - 20 minutes with no special preparation or precautions necessary.
The Annihilyzer System doesn't stop there, though. The icing on the cake is our state-of-the-art whole-room and handheld electrostatic sprayers that make quick work of completely disinfecting a room. Our 460D disinfectant can even be used to disinfect floors without leaving a haze or residue. We use a powerful non-synthetic disinfectant along with an automated electrostatic spray cart and/or electrostatic sprayers and patented RFID tracking technology that together are unmatched the industry to ensure proper and complete application.
What can the Annihilyzer do?
Save time and money by generating disinfectant and all-purpose cleaner on-site, on-demand
Eliminate the toughest bacteria, viruses, and fungi, including C. diff, C. auris, MRSA, VRE, blood-borne pathogens, and more.
Create 'industry best' protocols and 'push' them out to your cleaning staff in real-time with the Annihilist dashboard and mobile app
Generate reports that show when the areas were cleaned, who cleaned them, and what was done
Increase staff efficiency and effectiveness with process tracking, training, and accountability
How does the Annihilyzer save companies money?
Costs associated with purchasing and managing chemicals – eliminated
Freight charges for chemical deliveries – eliminated
Chemical container disposal or recycling costs – eliminated
Personal protection gear for cleaning – eliminated
Wastewater disposal costs and related fines for non-compliance – eliminated
Workers comp claims due to chemical burns and fume inhalation – eliminated
Happier, healthier and more productive workers
Same or better cleaning power than traditional hazardous chemicals for less
Eliminates costs associated with ordering, inventorying and disposing of chemicals and containers
Versatile
Grieco added: “All of our hospital customers using our infection control system and disinfectant are utilising the systems as a front-line defence throughout their facilities, including in all public area such as restrooms, lobbies, waiting rooms, elevators, corridors, cafeterias, etc. all throughout the day and night and in the presence of patients, staff and visitors.”
What other Infection Control System can do that?
What other system can provide a disinfectant and cleaner?
Results
Why would a hospital sign a 5-year agreement with PCTL when they could have signed a 2 or 3 year agreement?
I'll tell you why - RESULTS RESULTS RESULTS
SUNY Downstate Medical Center chose to renew their contract with the Company for an additional five years after utilizing the system for one year.
What are the chances at some point in the future when the other SUNY hospitals (Syracuse and Stony Brook) Infection Control Contracts expire that they sign with PCTL?
Why has every hospital that went through the 60 day trial period decided to do a multi-year contract? I'll tell you why - RESULTS RESULTS RESULTS
How many hospitals are in NYC?
There are 62 acute care hospitals in New York City.
How many hospitals in NYC have at least one Annihilyzer System?
PCTL has installed at least 14 systems and gained 22.5% market share in NYC hospitals in less than 18 months.
Most Technologically Advanced Disinfection System Ever Created
Annihilyzer the future for Healthcare and other Industries
During the Coronavirus Pandemic a Hospital with the Annihilyzer in place was in a better position than a hospital without it. Many hospitals will be asking themselves what could we have done differently? If they know about the Annihilyzer, having one will certainly be one of their answers. This is not the last one so they have to put themselves in the best position for future events.
What is a better investment for a whole room Infection Control System:
Annihilyzer versus an UV system?
They both disinfect effectively however the Annihilyzer provides an additional products, an all purpose cleaner and handheld electrostatic sprayers that can be used in other parts of the hospital in the presence of people because it is “Green Certified”.
Also the Annihilyzer cost less than half that of one of the best UV system on the market, the Xenex “LightStrike” cost about $125,000,
Annihilyzer versus a Chemical (Hydrogen Peroxide) based system?
They both disinfect effectively however the Annihilyzer provides an additional products, an all purpose cleaner and handheld electrostatic sprayers that can be used in other parts of the hospital in the presence of people because it is “Green Certified”.
Chemical based solutions require protective equipment, are more expensive and are harsh on furniture and one company called Hanosil sells their machine for under $10,000 however it costs $20 in product to clean each room.
I am not aware.
We should be well past 25 systems.
Actually the shit hit the fan in January.
We just didn't know it.
The graph you are showing is for people that have been tested. If we had unlimited testing and more people were tested the graph would be much higher.
PCTL received the first 10,000 gallons order prepaid with expected recurring orders. I believe this is what triggered PCTL to expand production along with other orders they were receiving that was out of the ordinary due to Covid 19.
The build out or ramp up reached a pinnacle which led to Gary Grieco infamous words during the April 21, 2020 Stock Day
Podcast:
The conversation then turned to dilution and outstanding shares.
Grieco noted that dilution occurred prior to January 2020, but shared that any shares that are currently being issued are meant for growth. “We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
You said there was only 10,000 gallons shipped when there was actually 20,000 gallons shipped. Get your facts first, then you can distort them as you please.
Mark Twain
To me, the first PR clearly stated that they received prepayment from a repeat customer for 10000 gallons... and the following PR states that it was shipped. I agree it was worded like it was two orders. But if you read it closely it obviously ment it was the 2nd 10000 gallon order from that company...not they shipped 20000 gallons in march. It was only 10000. It was people on the board twisted/pushed/pumped it to make it seem they shipped 20000 gallons. In my opinion...of course.
20,000 gallons
Little River, South Carolina — (March 18, 2020) PCT LTD (OTC Pink: PCTL) ("PCTL") is pleased to announce they have obtained a large pre-paid order from an existing sub-registrant in the Midwestern United States for 10,000 gallons of a specific fluid solution, with regular, recurring orders expected to follow.
Little River, South Carolina — (March 25, 2020) PCT LTD (OTC Pink: PCTL) ("PCTL") is continuing to expand business operations at a rapid rate while experiencing a dramatic increase in inquiries and orders from new and existing clients. Following up on an earlier release from March 18th; a second 10,000-gallon fluid order has been shipped to an existing customer in the Midwest. Recurring orders to this sub-registrant are
expected to follow in the coming weeks.
Minimum S780,657 to a maximum 2 to 2.5 times that figure.
Why?
So there probably was very good sales of HOCL from the March 28, 2020 PR to the April 21, 2020 PR when Gary made his famous announcement:
“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
The third week into the 2nd quarter is when cash was really flowing.
How much?
Based on Gary’s statement of the ability to cover the burn-rate and the total 1st quarter expenses being $780,657 and dividing that by three it should be at least $260,219 per month. The majority of that figure probably comes from increased HOCL sales. Moving forward cash flow should move up with the increase of distributors and sales/leases of the flagship product, the Annihilyzer.
PCTL's financial reporting should be fixed for 3rd Quarter 10Q
From the PR dated August 3, 2020:
With the filing of the 10-K Annual Report, the company is now focused on completing their first quarter 10-Q report and continuing work on their second quarter 10-Q report.
“We appreciate the patience and understanding of our shareholders,” says PCT CEO Gary Grieco. “Our intention is always to complete our filings in a timely manner, and we are aware of the effect which late filings may have on shareholder value. We’re pleased to be able to file our 10-K Annual Report now and want to inform shareholders that now that the 10-K has been filed, the outstanding first quarter 10-Q will be filed as soon as is humanly possible.”
“We have our second quarter 10-Q on the radar as well and it is likewise in progress,” continues Grieco. “We want to assure shareholders that as our company continues to experience tremendous growth this year that we are taking steps both internally and externally to minimize or prevent extended delays from occurring in the future.”
You ain't seen nothing yet! “Unfortunately, the delay experienced in filing our 2019 10-K Annual Report impacted subsequent filings and caused unfortunate and unavoidable setbacks for those reports,” adds Grieco. “Now that our 2019 10-K Annual report and our first quarter 10-Q report have been filed, our second quarter 10-Q filing is imminent, and we are confident that future filings will not experience similar delays.”
Todays PR was to throw investors a bone about the 10Q:
imminent defined:
an indefinitely short period of time; instant
likely to occur at any moment; impending
likely or certain to happen very soon.
The 5 systems were already PRed August 5, 2020. Today's PR just confirmed installation.
Additional and ongoing activities in the US Healthcare market include, but are not limited to:
1. Installation of 5 additional systems with an existing NYC Hospital client.
2. Pending final approval for an additional installation of two systems at a third, existing NYC Hospital client.
3. In the quoting phase, an additional system order is pending approval for a large hospital network in upstate New York.
4. In the quoting phase, an additional system order is pending approval for a large hospital network in Connecticut.
5. In the quoting phase, an additional system order is pending approval for a large hospital network in Tennessee.
One down 4 to go in the coming days, weeks and months.
Expecting many system orders in the coming weeks and months.
The SNOWBALL effect is activated.
Not dreaming:
This is the IR announcement from the 2019 10K NOTE 14. SUBSEQUENT EVENTS:
On July 6, 2020, the Company entered into a consulting agreement. Pursuant to the agreement the consultant will provide investor relations services for a period of one year in consideration for $3,000 per month and the issuance of 1,000,000 common shares of the Company.
Two days later...
This is the consultant announcement from the 2020 1st 10Q NOTE 12. SUBSEQUENT EVENTS:
On July 8, 2020, the Company entered into a consulting agreement. Pursuant to the agreement the consultant will provide business development and introductory services for a period of five years in consideration for the issuance of 1,000,000 common shares of the Company and a 5% commission, paid in shares, for any investments brokered.
Cash is flowing
Covering "burn rate" expected
2019 2nd Quarter 10Q September 16, 2019:
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (The expected costs for the next twelve months):
Management projects these costs to total approximately $2,500,000. To minimize these costs, the Company intends to maintain its practice of controlling operating overheads with efficient facilities commitments, generally below market salaries and consulting fees, and rigorous prioritization of expenditure requirements. Based on its understanding of the commercial readiness of its products and technologies, the capabilities of its personnel (current and being hired), established business relationships and the general market conditions, management believes that the Company expects to be close to profitability by the end of the fourth quarter of 2019.
2019 3rd Quarter 10Q April 13, 2020:
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (The expected costs for the next twelve months include):
Management projects these costs to total approximately $2,500,000. To minimize these costs, the Company intends to maintain its practice of controlling operating overheads with efficient facilities commitments, generally below market salaries and consulting fees, and rigorous prioritization of expenditure requirements. Based on its understanding of the commercial readiness of its products and technologies, the capabilities of its personnel (current and being hired), established business relationships and the general market conditions, management believes that the Company expects to be close to profitability by the end of the fourth quarter of 2020.
2019 10K August 3, 2020
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (The expected costs for the next twelve months):
Management projects these costs to total approximately $2,700,000. To minimize these costs, the Company intends to maintain its practice of controlling operating overheads with efficient facilities commitments, generally below market salaries and consulting fees, and rigorous prioritization of expenditure requirements. Based on its understanding of the commercial readiness of its products and technologies, the capabilities of its personnel (current and being hired), established business relationships and the general market conditions, management believes that the Company expects to be covering its fixed operating expenses (“burn rate”) by the end of the third quarter of 2020.
2020 1st Quarter 10Q August 14, 2020:
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (The expected costs for the next twelve months):
Management projects these costs to total approximately $2,700,000. To minimize these costs, the Company intends to maintain its practice of controlling operating overheads with efficient facilities commitments, generally below market salaries and consulting fees, and rigorous prioritization of expenditure requirements. Based on its understanding of the commercial readiness of its products and technologies, the capabilities of its personnel (current and being hired), established business relationships and the general market conditions, management believes that the Company expects to be covering its fixed operating expenses (“burn rate”)by the end of the third quarter of 2020.
They have to follow SEC rules:
SEC Form NT 10-Q is required to be filed within 45 days following the end of each of a company's first three fiscal quarters. If the 10-Q cannot be filed in a timely manner, the company must file a Form 10-QT with the commission. A very common reason for an NT 10-Q is a merger or acquisition, which prevents results from being incorporated in time for the filing. The SEC provides for "unreasonable effort and expense," with a suitable explanation, as part of the application for relief. Late filings may also be because of uncertainty surrounding litigation, due to a company’s auditor not having yet completed its review of the company’s operations, a sign of a company in financial distress, or because a company emerging from bankruptcy needs more time to complete the required disclosures.
PCTL is not trying to be one of the big boys.
PCTL is a small company operating on a shoestring budget coming out of a horrible segment of toxic financing only to get a lifeline due to the need of HOCL because of Covid-19.
They were in the survival mode and are just starting to right the ship.
They are not out of the woods yet however they have some breathing room to try and do better.
PCTL used to put out all their financials on time.
Why?
They were not doing much on the revenue side. It was mostly research and development.
As the revenues started to build in my opinion the reports became more complicated and someone wasn't keeping up.
Lesson learned
Hopefully they stay on top of things moving forward.
If they was a "big boy" the would have an independent auditor working for their company only giving daily updates.
Because it is not ready.
They have been counting all the fluid money they have been making. It is talking longer than expected.
Unless a company updates their financial information daily or weekly
then they probably will have a difficult time trying to get their reports out on time.
PCTL is a small struggling company. Although financial reports are important, survival as a company becomes a priority and that has taken precedent over all else.
PCTL is on much more sturdier grounds overall and hopefully should get their future reports out on time.
This is the IR announcement from the 2019 10K NOTE 14. SUBSEQUENT EVENTS:
On July 6, 2020, the Company entered into a consulting agreement. Pursuant to the agreement the consultant will provide investor relations services for a period of one year in consideration for $3,000 per month and the issuance of 1,000,000 common shares of the Company.
This is the consultant announcement from the 2020 1st 10Q NOTE 12. SUBSEQUENT EVENTS:
On July 8, 2020, the Company entered into a consulting agreement. Pursuant to the agreement the consultant will provide business development and introductory services for a period of five years in consideration for the issuance of 1,000,000 common shares of the Company and a 5% commission, paid in shares, for any investments brokered.
Not liklely and probably not legal,
The report isn't released because it isn't done.
The company has to consolidate all their revenue streams.
Who knows when they got started as they had to work on the 10K and the 1st quarter 10Q. Hopefully is will be days not weeks as with the 10K. The last 10Q came 11 days after the 10K. This 10Q has a lot more revenue streams to gather with new hospital installs and distributors.